ATE422503T1 - Rekombinante polypeptide aus mycoplasma und impfstoffe - Google Patents

Rekombinante polypeptide aus mycoplasma und impfstoffe

Info

Publication number
ATE422503T1
ATE422503T1 AT96940634T AT96940634T ATE422503T1 AT E422503 T1 ATE422503 T1 AT E422503T1 AT 96940634 T AT96940634 T AT 96940634T AT 96940634 T AT96940634 T AT 96940634T AT E422503 T1 ATE422503 T1 AT E422503T1
Authority
AT
Austria
Prior art keywords
present
mycoplasma
immunogens
vaccines
vaccine preparations
Prior art date
Application number
AT96940634T
Other languages
English (en)
Inventor
Glenn Francis Browning
Michael Francis Duffy
Kevin George Whithear
Ian Douglas Walker
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE422503T1 publication Critical patent/ATE422503T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1253—Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cookers (AREA)
AT96940634T 1995-12-13 1996-12-13 Rekombinante polypeptide aus mycoplasma und impfstoffe ATE422503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN7127A AUPN712795A0 (en) 1995-12-13 1995-12-13 Recombinant vaccines

Publications (1)

Publication Number Publication Date
ATE422503T1 true ATE422503T1 (de) 2009-02-15

Family

ID=3791447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940634T ATE422503T1 (de) 1995-12-13 1996-12-13 Rekombinante polypeptide aus mycoplasma und impfstoffe

Country Status (6)

Country Link
US (1) US6171589B1 (de)
EP (1) EP0879244B1 (de)
AT (1) ATE422503T1 (de)
AU (1) AUPN712795A0 (de)
DE (1) DE69637833D1 (de)
WO (1) WO1997021727A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050255129A1 (en) * 2002-05-03 2005-11-17 Luc Montagnier Treatments and methods for treatment, diagnosis and prophylaxis
US20070154437A1 (en) * 2002-09-03 2007-07-05 Pingfan Rao Peptide-tagged proteins and methods of making and using thereof
US20040043463A1 (en) * 2002-09-03 2004-03-04 Pingfan Rao Peptide-tagged proteins and compositions for regulating features of the skin or hair; methods of making, and methods of using thereof
CA2508221C (en) * 2002-12-04 2017-01-03 Louis V. Kirchhoff Recombinant polypeptides for diagnosing infection with trypanosoma cruzi
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
FR2937738B1 (fr) * 2008-10-23 2013-02-15 Abag Utilisation de polypeptides isoles ayant des proprietes antigeniques vis-a-vis de mycoplasma pneumoniae, ainsi que des polynucleotides et anticorps correspondants
CN109342724A (zh) * 2018-10-31 2019-02-15 廖朝晖 一种检测肺炎支原体的试剂盒
CN110483644A (zh) * 2019-09-10 2019-11-22 山东硕景生物科技有限公司 肺炎支原体IgM抗体的阳性血清替代品及其制备方法
CN113024642B (zh) * 2021-03-08 2022-09-20 珠海丽禾医疗诊断产品有限公司 一种基于肺炎支原体的蛋白质及其制备方法和应用
KR102879994B1 (ko) * 2021-05-06 2025-11-04 광주과학기술원 선택성이 개선된 항균 펩토이드 및 이를 포함하는 항균용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945041A (en) * 1983-11-17 1990-07-31 Board Of Regents Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia
US5369005A (en) * 1987-01-09 1994-11-29 Board Of Regents, The University Of Texas System Method for mycoplasma detection in a biological sample
US5026636A (en) * 1987-11-10 1991-06-25 The University Of Texas Board Of Regents Methods and compositions for production of mycoplasmal adhesins

Also Published As

Publication number Publication date
WO1997021727A1 (en) 1997-06-19
AUPN712795A0 (en) 1996-01-11
EP0879244A4 (de) 2001-12-05
US6171589B1 (en) 2001-01-09
EP0879244B1 (de) 2009-02-11
DE69637833D1 (en) 2009-03-26
EP0879244A1 (de) 1998-11-25

Similar Documents

Publication Publication Date Title
NO20070621L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose
TR199801722T2 (xx) Peptit imm�nojenler.
NO950328L (no) Konjugater med svake immunogene antigener og syntetiske peptidbærere og vaksiner som inneholder disse
AR052377A2 (es) Polipeptidos y polinucleotidos de neisseria meningitidis, un huesped unicelular, un metodo para producir una secuencia de adn, un metodo para producir un polipeptido, un metodo para aislar el antigeno, una composicion farmaceutica, uso de una proteina para producir una vacuna destinada para la preve
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
ATE192192T1 (de) Stress-proteine epitopen
KR890701125A (ko) 무병원성 미생물 및 이의 용도
DE69533295D1 (de) Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
FR2697022B1 (fr) Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
DK0494294T3 (da) Bakterielle stressproteiner
AUPN712795A0 (en) Recombinant vaccines
BRPI0114510B8 (pt) multímero de polipeptídeo monomérico purificado, composição de vacina para profilaxia ou tratamento da infecção por vírus da hepatite e em mamíferos, kit de diagnóstico para infecção por vírus da hepatite e em amostras biológicas, método de diagnóstico in vitro da infecção por vírus da hepatite e em mamíferos, método para detecção in vitro de anticorpos totais contra o vírus da hepatite e em amostras biológicas, método para detecção in vitro do anticorpo igg contra o vírus da hepatite e em amostras biológicas e método para detectar in vitro o anticorpo igm contra o vírus da hepatite e em amostras biológicas
DK0763114T3 (da) Hepatitis G-virus og molekylær kloning deraf
HUP9901688A2 (hu) A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek
ATE137672T1 (de) Vom streptococcus m-protein abgeleitete synthetische peptide und damit hergestellte impfstoffe
KR20050027985A (ko) 쯔쯔가무시병 및 ＨＩＶ 감염에 대한 오리엔티아쯔쯔가무시 절단형 재조합 외막 단백질 ｒ47 및 ｒ56백신을 이용한 진단 및 치료
KR930701605A (ko) 엠. 튜버쿨로시스(M. tuberculosis)의 단백질 MTP 40의 뉴클레오타이드 및 아미노산 서열 및 이로부터 유도된 합성 펩타이드
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
NZ515332A (en) Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses
CA2286399A1 (en) Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
CA2109961A1 (en) Peptides for use in induction of t cell activation against hiv-1
RU94045154A (ru) Полипептиды, их фрагменты и варианты, препарат, днк вектор, клетка, способ продукции полипептида, вакцины, способы защиты, антитело и его фрагмент, их применение, применение днк, способ идентификации антигена
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
ATE174963T1 (de) Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties